Cormorant Asset Management, LP - NEOS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$369,000
+1.4%
50,6130.0%0.06%
+15.1%
Q1 2017$364,000
+23.0%
50,6130.0%0.05%
+32.5%
Q4 2016$296,000
-11.1%
50,6130.0%0.04%
+8.1%
Q3 2016$333,000
-29.1%
50,6130.0%0.04%
-44.8%
Q2 2016$470,000
-13.0%
50,613
+1.2%
0.07%
-17.3%
Q1 2016$540,000
-24.6%
50,0000.0%0.08%
-5.8%
Q4 2015$716,000
-31.9%
50,0000.0%0.09%
-48.8%
Q3 2015$1,051,00050,0000.17%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders